Quirónsalud-Backed VOLGA Trial Shows Improved Survival in Bladder Cancer
A Quirónsalud-backed VOLGA trial showed improved survival in bladder cancer, according to the headline.
Related stories
WESCO International Reports Quarterly Results
WESCO International reported results for the quarter ended September 30.
M impact | EQUITY | Oct 29, 2026, 03:15 PM UTC
NextDecade Reports Quarterly Results for Period Ended September 30
M impact | EQUITY | Oct 29, 2026, 03:06 PM UTC
United Insurance reports Q3 profit of 1.2 million dinars
M impact | EQUITY | Oct 29, 2026, 03:06 PM UTC
Microsoft shares reverse course, down 1.3%
M impact | EQUITY | Oct 29, 2026, 03:05 PM UTC
SHL Finance Q3 net profit SAR 11.575 million
M impact | EQUITY | Oct 29, 2026, 03:04 PM UTC
Forbright Inc Reports Quarterly Results for Quarter Ended September 30
M impact | EQUITY | Oct 29, 2026, 03:04 PM UTC